Margitta Worm

Active 1993–2025

281
Papers
34,768
Citations
100
h-index
265
i10-index

Citations

Citations per year for Margitta Worm1930: 1 citations1982: 1 citations1992: 1 citations1993: 1 citations1995: 6 citations1996: 6 citations1997: 7 citations1998: 12 citations1999: 21 citations2000: 24 citations2001: 13 citations2002: 20 citations2003: 15 citations2004: 16 citations2005: 35 citations2006: 29 citations2007: 68 citations2008: 98 citations2009: 93 citations2010: 91 citations2011: 110 citations2012: 96 citations2013: 111 citations2014: 177 citations2015: 221 citations2016: 191 citations2017: 296 citations2018: 306 citations2019: 1,091 citations2020: 1,129 citations2021: 1,404 citations2022: 1,058 citations2023: 957 citations2024: 1,462 citations2025: 637 citations2026: 5 citations1931–1981: no citations, so these years are not shown1983–1991: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,462 citing papers, 15.5% of this breakdownGermany: 1,476 citing papers, 9.3% of this breakdownUnited Kingdom: 1,084 citing papers, 6.8% of this breakdownItaly: 960 citing papers, 6.1% of this breakdownFrance: 701 citing papers, 4.4% of this breakdownSpain: 634 citing papers, 4% of this breakdownChina: 633 citing papers, 4% of this breakdownCanada: 544 citing papers, 3.4% of this breakdownSwitzerland: 540 citing papers, 3.4% of this breakdownJapan: 485 citing papers, 3.1% of this breakdownNetherlands: 482 citing papers, 3.1% of this breakdownDenmark: 407 citing papers, 2.6% of this breakdown
0%15.5%Other 34.3%

Fields

  • Medicine81.4%
  • Immunology and Microbiology7.8%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Neuroscience1.1%
  • Environmental Science0.7%
  • Health Professions0.6%
  • Other2.8%

Topics

  • Allergic Rhinitis and Sensitization10.6%
  • Food Allergy and Anaphylaxis Research9.7%
  • Dermatology and Skin Diseases9.6%
  • Asthma and respiratory diseases8.2%
  • Contact Dermatitis and Allergies3.1%
  • Urticaria and Related Conditions3%
  • Other55.8%

Coauthors

All papers

Open in search
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 2,045

  2. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Authors: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 cited by 595

  3. World Allergy Organization Anaphylaxis Guidance 2020

    Authors: , , , , , , , , , , , , , , , - World Allergy Organization Journal 2020 cited by 1,096

  4. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernhard Hube, Olaf Kniemeyer, Axel A. Brakhage, C. Schwarz, Alexander Scheffold - Cell 2019 cited by 483

  5. EAACI guidelines on the diagnosis of IgE‐mediated food allergy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marek Jutel, Edward F. Knol, George Ν. Konstantinou, Gideon Lack, Susanne Lau, Andreina Marques‐Mejias, Mary Jane Marchisotto, Rosan Meyer, Charlotte G. Mørtz, Beatriz Moya, Antonella Muraro, Caroline Nilsson, Lucila Camargo Lopes de Oliveira, Liam O’Mahony, Nikolaos G. Papadopoulos, Kirsten P. Perrett, Rachel L. Peters, Márcia Helena Miranda Cardoso Podestá, Lars K. Poulsen, Graham Roberts, Hugh A. Sampson, Jürgen Schwarze, Peter Smith, Elizabeth Huiwen Tham, Eva Untersmayr, Ronald van Ree, Carina Venter, Brian P. Vickery, Berber Vlieg‐Boerstra, Thomas Werfel, Margitta Worm, George Du Toit, Isabel Skypala - Allergy 2023 cited by 271

  6. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karla Soares‐Weiser, Aziz Sheikh, Barbara Ballmer‐Weber, Caroline Nilsson, Nicolette W. de Jong, Cezmi A. Akdiş, the EAACI Food Allergy and Anaphylaxis Guidelines Group - Allergy 2014 cited by 1,360

  7. EAACI guidelines: Anaphylaxis (2021 update)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Allergy 2021 cited by 575

  8. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frans Timmermans, Olympia Tsilochristou, E.‐M. Varga, J. N. Wilkinson, Andrew B. Williams, Luo Zhang, Ioana Agache, Elizabeth Angier, Montserrat Fernández‐Rivas, Marek Jutel, Susanne Lau, Ronald van Ree, Dermot Ryan, Gunter J. Sturm, Antonella Muraro - Allergy 2017 cited by 777

  9. Managing food allergy: GA2LEN guideline 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Loh, Montserrat Álvaro‐Lozano, Mika J. Mäkelä, Mary Jane Marchisotto, Rosan Meyer, E. N. Clare Mills, Caroline Nilsson, Anna Nowak‐Węgrzyn, Ulugbek Nurmatov, Giovanni Battista Pajno, Márcia Helena Miranda Cardoso Podestá, Lars K. Poulsen, Hugh A. Sampson, Ángel Sánchez, Sabine Schnadt, Hania Szajewska, Ronald van Ree, Carina Venter, Berber Vlieg‐Boerstra, Amena Warner, Gary Wong, R.J.K. Wood, Torsten Zuberbier, Graham Roberts, Priya Bansal, Roberto Berni Canani, Katharina Blümchen, Andreas Bonertz, M. Bourgoin‐Heck, Ozlem Ceylon, Amandine Divaret‐Chauveau, David M. Fleischer, Maximiliano Gómez, Marion Groetch, Domingo Barber Hernandez, Betina Hjorth, Lydia Collins Hussey, André C. Knulst, Agnes Sze Yin Leung, Douglas P. Mack, Vera Mahler, Francesca Mori, Leyla S. Namazova-Baranova, Kati Palosuo, Claudio Alberto Salvador Parisi, Antônio Carlos Pastorino, Odilija Rudzevičienė, Maria Said, Piotr Sawiec, Scott H. Sicherer, Sakura Sato, Світлана Зубченко - World Allergy Organization Journal 2022 cited by 200

  10. Frequency of food allergy in Europe: An updated systematic review and meta‐analysis

    Authors: , , , , , , , , , , , , , , , - Allergy 2022 cited by 231

  11. Trial of Intravenous Immune Globulin in Dermatomyositis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 206

  12. Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Dermatology 2019 cited by 206

  13. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 cited by 566

  14. Prevalence estimates of eight big food allergies in Europe: Updated systematic review and meta‐analysis

    Authors: , , , , , , , , , , , , , , , - Allergy 2023 cited by 133

  15. Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 333

  16. Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)*

    Authors: , , , , , - British Journal of Dermatology 2021 cited by 92

  17. Risk factors for severe reactions in food allergy: Rapid evidence review with meta‐analysis

    Authors: , , , , , , , , , , , , , , - Allergy 2022 cited by 142

  18. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziad Reguiai, Claire Bernier, Camille Leleu, Julien Seneschal, Delphine Staumont-Sallé, Thomas Hubiche, Caroline Jacobzone, Abdallah Khemis, Marie-Noëlle Crépy, Margitta Worm, Andrea Bauer, Sabine Sell, Swarna Ekanayake-Bohlig, Sylvia Pauser, Timo Buhl, Andreas Schwinn, Bernadette Eberlein, Sven Quist, Boris Bauer, Ketty Peris, Maria Teresa Rossi, Maria Fargnoli, Luigi Naldi, Luca Stingeni, Silvia Ferrucci, Irena Walecka-Herniczek, Dorota Krasowska, Aleksandra Lesiak, Aleksandra Okuniewska, Grażyna Pulka, Malgorzata Dyczek, Bartlomiej Kwiek, Rafal Czajkowski, Hanna Myśliwiec, Padma Mohandas, Sandeep Cliff, Richard Warren, Pippa Cousen, Graham Johnston, Richard Woolf, Kim Papp, David Adam, Darryl Toth, Chih-ho Hong, Irina Turchin, Firouzeh Niakosari, Elena Poulos, Jason Rivers, Jason Ohayon, Melinda Gooderham, Milan Tjioe, Thomas Rustemeyer, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar, Judith Molhoek, Bert Oosting, Andreas Pinter, Markus Kaspari, Nina Magnolo, Michael Sebastian, Diamant Thaci, Sibylle Schliemann, Peter Radny, Nicolas Leitz, Athanasios Tsianakas, Amir Yazdi, Maria Kamstrup, Mette Sommerlund, Claus Zachariae, Witold Owczarek and 20 more - The Lancet 2024 cited by 89

  19. The pan‐JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase IIb trial*

    Authors: , , , , , , , , , - British Journal of Dermatology 2022 cited by 88

  20. Guideline on allergen immunotherapy in IgE-mediated allergic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margitta Worm, Bettina Wedi - Allergologie select 2022 cited by 115

  21. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2023 cited by 76

  22. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 599

  23. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression

    Authors: , , , , , , , - Nature Medicine 2005 cited by 477

  24. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Authors: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 95